COVID-19 a Key Focus for World Suicide Prevention Experts in Australia This Year

IASP 31st World Congress

IASP 31st World Congress

Australia will be in the world spotlight this September as lead international experts gather to share ways to tackle the potential impact of COVID-19 on suicide

GOLD COAST, AUSTRALIA, February 26, 2021 /EINPresswire.com/ — The International Association for Suicide Prevention (IASP) 31st World Congress will be held in Australia, with COVID highlighted as the key focus for delegates.

IASP President Professor Rory O’Connor has been part of a leading group of international researchers and practitioners, looking into COVID-19 and suicide prevention.

“Over the past 10 months, our experience of the COVID-19 pandemic has highlighted the need for greater awareness, knowledge, research and action related to mental health and suicide prevention.“ said Professor O’Connor.

“As a result, I am looking forward to the 31st World Congress, as it will shine a light on how mental health and suicide prevention can continue to play a vital role as we recover from COVID-19 and support the most vulnerable.”

There is no current evidence that during this pandemic there has been an increase suicide rates, other than data from Japan in early 2021 of an increase in suicides among young people.

However, there is no room for complacency. We know from the research from traumatic events, such as natural disasters, it’s in the post-event period where we typically see the potential for an increase in suicidality, hence the move to increase prevention efforts now.

“At a time when there is considerable concern about the impact of COVID-19 on mental health and suicide rates, both in Australia and elsewhere, the 31st World Congress is a unique opportunity to learn, share and advocate for the need for greater awareness around suicide a reduction in stigma associated with it and more action to prevent it,” Professor O’Connor.

“For many years, the IASP World Congresses have been seminal events for learning about the latest developments in suicide prevention globally.”

Suicide is a public health issue that affects individuals, families, workplaces and communities the world over. It remains a universal challenge with millions impacted by suicidal behaviour. Suicide is among the top 20 causes of death globally for people of all ages (approximately 800,000 per year, with over 3,000 in Australia). Indigenous peoples in Australia have among the highest global rates.

Limited data means the true extent of suicidal behaviour remains hidden (approximately 20 attempted suicides per suicide) and suicide is far-reaching, leaving many affected and/or suffering intense grief (approximately 135 people per suicide). The reduction of suicide mortality is of global importance and a vital public health consideration.

Pro-Vice Chancellor (Health) at Griffith University, Professor Sheena Reilly said the congress, which is being delivered in partnership with Griffith, could not come at a more crucial time.
“The conference will bring together national and international experts on the Gold Coast to learn from each other and provide an opportunity to access the very best research,” Professor Reilly said.
“Griffith University has a long history of research in suicide and suicide prevention through the Australian Institute for Suicide Research and Prevention (AISRAP), which was established in 1996. Griffith’s AISRAP is proud to be a long term partner with the IASP, recognising the key role that both organisations play in advancing our understanding of and prevention of suicide.”

IASP is particularly proud to be hosting this congress in Australia at this time as the country continues to make enormous strides in its efforts to prevent suicides.

With a clear, unequivocal commitment from the States and Federal governments and with the Australian Prime Minister taking a leading role in furthering suicide prevention efforts, Australia plays an exemplary role in how nations can integrate suicide prevention efforts through reform, policy and application.
“The Queensland Government, through Tourism and Events Queensland, is proud to support business events like this which are vital to Queensland's tourism industry – attracting visitors, supporting local jobs and promoting our destinations,” Tourism & Events Queensland.

The IASP World Congress is the primary global collaborative opportunity for expert thinking related to suicide and suicide prevention, bringing together academics, researchers, practitioners, those with lived experience, diverse backgrounds, and innovators associated with suicide prevention efforts or working within suicide prevention related topics.

“The 31st World Congress comes at a time where it is so important that we listen to the voice of lived experience, those from diverse backgrounds, and encourage emerging research leaders early in their careers” says Professor O’Connor.

The congress takes place on the Gold Coast, Queensland and virtually from 21st – 24th September 2021. Early bird registrations for attendance are open from 1st February 2021.
The Congress will be fully hybrid with the full programme available in person and virtually online
For more information and to register for the event, visit: https://www.iasp.info/goldcoast2021/registrations/
ENDS :

Contacts:
General communication enquiries:
• Globally: Communications@iasp.info Marketing & Communications Katherinethomson@iasp.info
• Australia: 0427227503 Marc Bryant marc.bryant@livingworks.com.au

Media talent: Professor Rory O’Connor: has a long-standing interest in suicide research and prevention; he has been working in the field since 1994. He is Professor of Health Psychology at the University of Glasgow in Scotland and Past President of the International Academy of Suicide Research. Rory leads the Suicidal Behaviour Research Laboratory (www.suicideresearch.info) at the University of Glasgow, one of the leading suicide and self-harm research groups in the UK.

Notes for editors:
The International Association for Suicide Prevention (IASP) leads the global effort in suicide prevention having developed an effective forum that is proactive in creating strong collaborative partnerships and promoting evidence-based action in order to reduce the incidence of suicide and suicidal behaviour (www.iasp.info). Established in 1960, IASP is the largest international association dedicated to suicide prevention and to the alleviation of the effects of suicide and collaborates closely with relevant international organisations.

Griffiths University and the Australian Institute for Suicide Research and Prevention (AISRAP) is the official partner for the IASP 31st World Congress. https://www.griffith.edu.au/griffith-health/australian-institute-suicide-research-prevention

Important note: Journalists reporting on this event are advised to include information on relevant help lines and websites. The following website provides details of Crisis Centres around the globe: https://www.iasp.info/resources/Crisis_Centres/

Journalists reporting on this event are also advised to adhere to the following guidelines;
Guidelines related to reporting on suicide during the COVID-19 pandemic.

General guidance for communicating about suicide.

Katherine Thomson
International Association for Suicide Prevention
+44 7470 596521
katherinethomson@iasp.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Brazilian Patent Allowance for Obesity Pet Vaccines to Braasch Biotech LLC.

obesity in dogs

obesity in cats

Novel vaccines for therapeutic treatment of obesity in pets (dogs, cats, horses)

GARRETSON, SD, US, February 26, 2021 /EINPresswire.com/ — Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Brazilian Intellectual Property Office for Braasch’s patent entitled “Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone Deficiency.”
The Patent Allowance provides claims for the therapeutic treatment for obesity in dogs, cats and horses. The source of obesity includes both diabetic and non-diabetic causes. The Braasch vaccine technologies, like other veterinary vaccines, utilize specific immunological responses post-vaccination. In the case of the Braasch vaccine, the endogenous hormone somatostatin is targeted. By attenuating the effects of this counter-regulatory hormone, a therapeutic effect on obesity is realized. Unlike other vaccines, the Braasch vaccine’s mode of action is by B-cell epitope enhancements which produces an antibody response within 4 days (US Patent 10,441,652 B1, October 2019).
“Like human obesity, obesity in dogs and cats is at epidemic proportions. Although prevention is always the best option, once an animal reaches the obese state, owner intervention is necessary for the pet’s continued quality of life and longevity. Currently there are no commercially available therapeutic treatments for both dogs and cats, stated Jeralyn Kay Haffer, CEO and Chairman of Braasch. “We are now pleased the Brazilian Intellectual Property Office also has recognized the vaccine’s novelty and commercial utility in the fight against obesity.”
Braasch’s intellectual property portfolio includes multiple patent families with issued or pending claims directed to utility of anti-somatostatin vaccine technologies, Somatovac® for multiple metabolic challenges. These applications relate to both human and veterinary use of the technologies.
About Braasch Biotech
Braasch Biotech is a biopharmaceutical company with a focus on the development and commercialization of innovative products of therapeutic approaches utilizing Somatovac® technologies. Currently in the Product Pipeline are vaccines for livestock productivity enhancement, increased fertility, GH/IGF-1 deficiencies and obesity treatment. To date, Braasch has multiple regulatory submissions in progress on the use of vaccines in metabolic regulation of dairy cows and pigs. Braasch Biotech is a privately held biopharmaceutical with corporate offices in South Dakota.
For more information on Braasch Biotech, please email info@braaschbiotech.com or visit www.braaschbiotech.com.

Keith N. Haffer
Braasch Biotech LLC
605-376-8756
keith.haffer@braaschbiotech.com


Source: EIN Presswire

RollsPack – Award Winning Packaging Company brings Returnable Mailer Bag to the Australian market for 2021

RollsPack Australia Logo - Wholesale and Retail Packaging Supplier

RollsPack Australia Logo

RollsPack introduces the Boomerang Bag  a new returnable mailer bag - White Poly bag with a twice use seal.

RollsPack introduces the Boomerang Bag a new returnable mailer bag

RollsPack Office in Braeside Victoria

RollsPack Office in Braeside Victoria

A remarkable 96% of customers won't shop with you again – if they can't return a product easily

One study featured in the Journal of Marketing found that customers who received free shipping on returns increased their purchases over the next two years by 58% to 357% .”

— bigcommerce dot com

PORT MELBOURNE, VICTORIA, AUSTRALIA, February 26, 2021 /EINPresswire.com/ — RollsPack (Australia's favourite wholesale and retail packaging supplier https://rollspack.com.au/ ) is proud to release our new 'Boomerang Bag' – a returnable, reusable & recyclable mailer bag which makes it simple for shoppers to return unwanted items and which can be sustainably recycled at local supermarkets.

During lockdown multiple studies have show that people 'impulse buy', shopping therapy is at an all time high – however this has created a bit of a problem. Often when items are in high demand and shoppers impulse buy, this may result in them needing to return the product.

About 35 % of people claim that they have made impulse transactions to deal with the burden of the coronavirus pandemic, according to a new study commissioned by Credit Karma, a personal finance platform where customers can review their credit score. Interestingly only 3% of respondents said that they 'never impulse buy' – These statistics may be even more prevalent in the Australian market, as we have faced more severe lock downs. Meaning our exposure to isolation based shopping decisions has been greater, as has our general reliance on e-commerce retail infrastructure.

RollsPack (an Australian company) have been in the packaging game for over 30 years, offering solutions in the market including; food packaging, retail packaging, tamper-evident packaging, and e-commerce packaging. In fact, the twice-use satchel is a concept that RollsPack pioneered. With the boom of e-commerce and with fashion-based brands needing a 'returnable' solution, we felt it was time to introduce the new and improved returnable mailer… the Boomerang Bag.

Named after a cultural item of its country of origin, the Boomerang Bag aims to reduce waste and pollution, our partnership with REDcycle means that these mailers can be taken to a local supermarket and disposed of sustainably. The program is a partnership between manufacturers, retailers and consumers. The REDcycle team place specially marked bins at Coles & Woolworths supermarkets which consumers can drop their soft plastics into. The collected products are returned to RED Group’s facility for processing then delivered to Australian manufacturer Replas where it is transformed. The resulting recycled-plastic products are extremely robust, as well as water and termite resistant. They won’t crack, splinter or rot and will never need painting.

We are always searching for new and creative ways to add value through innovation, and having pioneered the now popular 'twice use' mailer, it seemed a great fit for our next initiative. If you are looking to take your brand to the next level, offering a pleasant packaging experience at one of the last touchpoint opportunities in the modern buying process, talk to us about the Boomerang Bag.

Call us today to discuss the Boomerang Bag. (03 9588 0055)

Will Paton
RollsPack Pty Ltd
+61 3 9588 0055
customerservice@rollspack.com.au
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

SmartBot360's Chatbot AI Upgraded With Document Search to Increase Responsiveness For COVID Queries

RIVERSIDE, CALIFORNIA, US, February 25, 2021 /EINPresswire.com/ — As the number of COVID tests and vaccinations grows, SmartBot360, an AI-powered healthcare chatbot, released a new feature that allows companies to easily set up a chatbot to respond to common COVID questions. Whether a website has a dedicated page or a small section for COVID questions, SmartBot360’s document search makes it easy to help patients find the information they need by processing a patient’s query and responding with relevant information. If a patient’s query cannot be answered by the information in the chatbot flow, FAQ matching kicks in, and if there is still no match, the document search feature kicks in, which uses contextual understanding to find a page on the website that has relevant information. The results are returned in a carousel view with links to help patients quickly navigate to relevant pages.

SmartBot360’s COVID chatbot is currently utilized by Midwest Express Clinic in Illinois, True Health in Florida, and HealthPoint in Washington, among others, to smoothly handle the increasing demand and queries of patients looking to get COVID testing or the vaccine.

With vaccine distribution ramping up across the U.S., more and more healthcare providers are being inundated with questions regarding the COVID vaccine. SmartBot360 is meant to help scale and improve the customer service of healthcare businesses while preventing call centers from being overloaded with COVID questions. From helping patients figure out the vaccine process and helping them schedule an appointment to automated follow-ups, document search helps patients to find a solution to their answer.

“Customer experience has always been the priority when developing SmartBot360’s AI, including how to answer as many questions as possible and reducing the drop-off rate of chatbots. Patients drop-off due to unanswered questions or confusion when talking to a chatbot,” said Vagelis Hristidis, Ph.D., founder of SmartBot360. Document search is a feature meant to reduce drop-off rates while being more effective at helping patients navigate a website. “We want to minimize customer service time so employees can focus on more complex questions while using the chatbot to answer repetitive, common questions.”

Learn more on the SmartBot360 website: https://smartbot360.com

Vagelis Hristidis
SmartBot360
+1 949-229-2045
vagelis@smartbot360.com


Source: EIN Presswire

SmartBot360's Chatbot AI Upgraded With Document Search For Increasing COVID Queries

RIVERSIDE, CALIFORNIA, US, February 25, 2021 /EINPresswire.com/ —

As the number of COVID tests and vaccinations grows, SmartBot360, an AI-powered healthcare chatbot, released a new feature that allows companies to easily set up a chatbot to respond to common COVID questions. Whether a website has a dedicated page or a small section for COVID questions, SmartBot360’s document search makes it easy to help patients find the information they need by processing a patient’s query and responding with relevant information. If a patient’s query cannot be answered by the information in the chatbot flow, FAQ matching kicks in, and if there is still no match, the document search feature kicks in, which uses contextual understanding to find a page on the website that has relevant information. The results are returned in a carousel view with links to help patients quickly navigate to relevant pages.

SmartBot360’s COVID chatbot is currently utilized by Midwest Express Clinic in Illinois, True Health in Florida, and HealthPoint in Washington, among others, to smoothly handle the increasing demand and queries of patients looking to get COVID testing or the vaccine.

With vaccine distribution ramping up across the U.S., more and more healthcare providers are being inundated with questions regarding the COVID vaccine. SmartBot360 is meant to help scale and improve the customer service of healthcare businesses while preventing call centers from being overloaded with COVID questions. From helping patients figure out the vaccine process and helping them schedule an appointment to automated follow-ups, document search helps patients to find a solution to their answer.

“Customer experience has always been the priority when developing SmartBot360’s AI, including how to answer as many questions as possible and reducing the drop-off rate of chatbots. Patients drop-off due to unanswered questions or confusion when talking to a chatbot,” said Vagelis Hristidis, Ph.D., founder of SmartBot360. Document search is a feature meant to reduce drop-off rates while being more effective at helping patients navigate a website. “We want to minimize customer service time so employees can focus on more complex questions while using the chatbot to answer repetitive, common questions.”

Learn more on the SmartBot360 website: https://smartbot360.com

Vagelis Hristidis
SmartBot360
+1 949-229-2045
vagelis@smartbot360.com


Source: EIN Presswire

Wynonna Judd Launches WYNONNA CBD Product Line

WYNONNA CBD

WYNONNA CBD Oil

WYNONNA CBD Balm

WYNONNA CBD Bath Bombs

Custom formulated to the specifications of the Country music queen herself, WYNONNA CBD is a luxurious new line of herbal-infused hemp-derived products.

We finally found something that works for me and I want my fans to benefit as well.”

— Wynonna Judd

NASHVILLE, TN, USA, February 25, 2021 /EINPresswire.com/ — Grammy-winning Country music icon, Wynonna Judd, has partnered with Nashville-based CeleBriDy Brands to develop WYNONNA CBD. Custom formulated to the specifications of the Country music queen herself, WYNONNA CBD is a luxurious new line of herbal-infused hemp-derived products designed to help bring harmony to your everyday life.

WYNONNA CBD offers a premium hemp extract oil, topical balm and luxourious bath bombs, all made using organic extracts from hemp grown in the USA and responsibly sourced, all-natural ingredients. Manufactured in Nashville, Tennessee, WYNONNA CBD’s hemp extract is infused with a soothing and harmonious blend of vanilla and lavender to promote balance and relaxation. The balm features a blend of essential oils, hemp extract, and Vitamin E, designed to provide topical relief day or night.

“We need to relax, we need balance," says Wynonna. "Everybody’s just processing a lot of stuff. I’m constantly talking about my own healing and recovery process. I was famous at 18, I’m an introvert, and I’ve battled anxiety since the beginning of the Judds. We finally found something that works for me and I want my fans to benefit as well."

“We are thrilled to partner with Wynonna Judd,” says CeleBriDy Brands founder Brian Mayes. “Wynonna is not just a legendary artist, but a trusted friend to fans worldwide. She has shared her life with them for nearly four decades, and they trust her. And that is why it was imperative that we create a premium product that is worthy of her name. Wynonna put her personal touch on WYNONNA CBD products from start to finish, and we know they will help people tune in to themselves and the things that really matter.”

WYNONNA CBD is available exclusively at www.WynonnaCBD.com.

About Wynonna Judd: Five-time Grammy winner and New York Times best-selling author, Wynonna has always revolved her career around telling stories. Whether performing alongside her mother as one half of the legendary duo The Judds, or pushing the boundaries on her own mega-successful solo path, Wynonna’s ability to reach the heart of the human spirit through her bold and unflinching honesty, is the entertainer’s true gift. Once dubbed by Rolling Stone as “the greatest female country singer since Patsy Cline,” Wynonna’s rich and commanding voice has sold over 30 million albums worldwide spanning her remarkable 36-year career. Wynonna has received over 60 industry awards, with countless charting singles, including 20 No.1 hits such as “Mama He’s Crazy,” “Why Not me,” and “Grandpa (Tell Me ‘Bout The Good Ole Days).”

About CeleBriDy Brands: CeleBriDy Brands LLC is a Nashville-based company that creates and markets celebrity-branded CBD products, with numerous products currently in development. The company’s flagship product line, John Schneider’s CBoD ("C-Bo-D”), launched in January 2020 on Fox & Friends and Fox Business. It was an immediate success with explosive sales, making CeleBriDy Brands a significant sales leader in the fast-growing American CBD market.

Brian Mayes
Nashville Publicity Group
+1 615-771-2040
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Monica Gillison Joins LTEN Advisory Council

Monica Gillison

Life sciences trainers associations welcomes SK Life Science training leader, Monica Gillison, to organization's leadership team.

ROANOKE, VA, UNITED STATES, February 25, 2021 /EINPresswire.com/ — Life sciences training leader Monica Gillison has been selected to join the LTEN Advisory Council. Her appointment begins immediately.

Gillison, senior manager of commercial sales training for SK Life Science, has worked in life sciences since 1998, when she started as a senior specialty neuroscience representative for Eli Lilly. Since then, Gillison has held sales, training and leadership roles at Amylin Pharmaceuticals, Zogenix and Collegium Pharmaceuticals. Gillison has also served as Guest Editor of LTEN Focus on Training magazine and was a finalist for the 2020 All-Star Teams category of the LTEN Excellence Awards competition.

“It’s an honor to be asked to join the LTEN Advisory Council, and I’m looking forward to working with the Council members and also with the Board of Directors,” Gillison said. “In my time with LTEN I’ve seen the positive effect our network has on training careers, and I’m excited to help deliver valuable programs and work that raises the bar for all members.”

“It was a great choice to bring Monica’s impressive energy to the LTEN Advisory Council,” said Dawn Brehm, LTEN executive director. “Since joining LTEN, she’s been a great contributor to our publications and events, and I know this new role will be a nice fit for her. As the Advisory Council supports the Board of Directors in creating new initiatives, Monica’s experience and drive will be valuable assets to support LTEN members and leadership.”

ABOUT LTEN
The Life Sciences Trainers & Educators Network (www.L-TEN.org) is the only global 501(c)(3) nonprofit organization specializing in meeting the needs of life sciences learning professionals. LTEN shares the knowledge of industry leaders, provides insight into new technologies, offers innovative solutions and communities of practice that grow careers and organizational capabilities. Founded in 1971, LTEN has grown to more than 2,100 individual members who work in pharmaceutical, biotech, medical device and diagnostic companies, and industry partners who support the life sciences training departments.

MEDIA CONTACT
For more information contact Nannette Nolan, LTEN director of marketing communications, at nnolan@L-TEN.org.

Nannette Nolan
Life Sciences Trainers & Educators Network
+1 424-266-0745
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Dental Marketing Leader To Deliver Two High Impact Courses at 156th Chicago Dental Society Midwinter Meeting

AIM Dental Marketing Logo

Since 1989 AIM has helped dentists across North America take aim with their marketing

On Saturday, February 27, 2021, Daniel A. Bobrow, AIM Dental Marketing's president will deliver lectures on telephone skills mastery and dental cause marketing.

Bobrow is also Exec. Dir. of Climb for a Cause, creator of The Art of First Impressions, host of the Practice Perfection web-based education series, and co-inventor of the Dental Marketing Dashboard.”

— Andrew Sutton

CHICAGO, IL, UNITED STATES, February 25, 2021 /EINPresswire.com/ — At 8:00 a.m. Central on Saturday, February 27th, AIM Dental Marketing president Daniel A. "Danny" Bobrow, MBA (finance), MBA (marketing) will deliver an abbreviated version of his acclaimed Master The Art of First Impressions: Make Every Call An Appointment lecture.

Drawing upon his 31 years of experience, Bobrow will share and guide attendees through the mind and skill sets that make it simple to connect with any caller to schedule a solid and kept appointment.

Mr. Bobrow will reveal how to quickly and easily establish rapport, convey empathy, exude enthusiasm, ask the right questions in the right way at the right time, and employ effective listening technique to connect with and guide callers to a firm dental appointment.

Learn more about Bobrow's Lecture at: https://www.eventscribe.net/2021/CDSvMWM/agenda.asp?startdate=2/27/2021&enddate=2/27/2021&BCFO=V&pfp=Lectures&tn=&cpf2=&cus2=&pta=

Then at 11:00 a.m., Bobrow will Deliver Doing Well By Doing Good: Wrap Your Practice In A Blanket Of Caring. Attendees will be exposed to a dental practice builder that requires no selling, costs nothing to implement, enhances patient loyalty, encourages referrals, attracts new patients, builds team camaraderie, positions the dentist as a coveted media source, and does far more good for ones chosen cause than ever imagined possible.

Attendees will leave equipped with the skills to: reduce team turnover, enhance team engagement, increase job satisfaction, and generate more production from new and existing patients.

Learn more about Bobrow's Lecture at: https://www.eventscribe.net/2021/CDSvMWM/agenda.asp?startdate=2/27/2021&enddate=2/27/2021&BCFO=V&pfp=Lectures&tn=&cpf2=&cus2=&pta=

Daniel A. ‘Danny’ Bobrow is President of AIM Dental Marketing. He is also Executive Director of Climb for a Cause, creator of The Art of First Impressions telephone skills mastery curriculum, host of the Practice Perfection web-based education series, and co-inventor of the Dental Marketing Dashboard.

Danny lectures nationwide, and has been published in numerous professional publications. He is a Certified mediator and arbitrator, Charter Member of the Speaking Consulting Network, and founding executive chair for the American Academy for Oral Systemic Health.

He holds a Bachelor of Science degree in Economics from The University of Illinois, and Masters of Business Administration Degrees (MBAs) in finance and marketing from The University of Chicago and K.U.L. Belgium, respectively.

His passions include skiing, cycling, adventure racing, kayaking, and mountaineering.

Danny is a certified health coach and personal trainer, which serves to round out his passion for helping professionals lead by example.

Daniel A. Bobrow
American Dental Corporation
312-455-9488
dbobrow@aimdentalmarketing.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Integra Medical Center Celebrates its 30th Anniversary

Front Desk Integra Medical Center

Front Desk at Integra Medical Center

Current staff at Integra Medical Center

Current staff at Integra Medical Center

Since 1991, Integra Medical Center has been a leading Regenerative Medicine Clinic in the Nuevo Progreso Area. For the world.

NUEVO PROGRESO, TAMAULIPAS , MEXICO, February 25, 2021 /EINPresswire.com/ — Since its founding in 1991, Integra Medical Center has been a pioneer clinic in Regenerative Medicine procedures based on Stem Cells in Nuevo Progreso, Mexico, for the world. Its staff is proud of practicing multiple modalities of therapy, that Dr. Omar Gonzalez incorporated into his practice after extensive reviewing, and always matching his principles and values like minimal side effects, best effectiveness, and affordability.

Dr. Gonzalez and his team are always in constant and continuous education. He's been in multiple countries in Europe, Asia, and the United States, validating and reinforcing his protocols and techniques. All in an effort to offer the best care for multiple diagnoses and conditions.

For 30 years Acupuncture and Stem Cell therapy have been the staple procedures offered; cosmetic surgeries, Laser therapy, Transcranial Magnetic Stimulation, are some of the newest treatments being currently offered.

Personalized care has always been a must, along using the best technology, either in the surgery room, IV room, and at all the clinic's facilities. Special attention has been placed to create the most confortable spaces for treatment and recovery.

Besides the proprietary protocols for an ample range of diseases, from anti-aging to degenerative conditions such as Parkinson's Disease. Multiple Sclerosis, and Alzheimer's, Integra Medical Center offers Medical Aesthetic treatments, Like the revolutionary Morpheus8 for skin rejuvenation.

Integra Medical Center's Dr. Omar Gonzalez and staff remain proud of helping improve the quality of life of countless patients from literally around the globe.

To learn more visit: www.integramedicalcenter.com

About Dr. Omar Gonzalez:

Dr. Omar D Gonzalez believes in a multi-disciplinary approach to medicine. He practices state- of-the-art anti-aging techniques and combines the best of European, North American, traditional and Chinese medicine. He has practiced different modalities of Integrative Medicine from Western orthodox medicine and others like Acupuncture; Neural Therapy; Acutome therapy; Laser therapy and Immune Modulating therapy like Term Placenta Stem Cell Therapy since 1991.

Dr. Gonzalez belongs to the International Placenta Stem Cell Society; The Mexican Board of Medical Acupuncture; The Board of Aesthetic Surgery and Longevity and has continued his education at different Universities including Wake Forest, Rice, TERMIS, IPLASS, IESM.

Adalberto Loredo BME
Integra Medical Center
+1 956-475-4368
info@integramedicalcenter.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Leading New York State Hospitals Deploy Intelligent New Autonomous Robots to Combat Pandemic

Black-I Environmental PureTech autonomous disinfectant robot at work in Rochester, NY, hospital

Among the first hospitals in the country to embrace mobile robot for fast, deep, cost-effective disinfecting

Hospitals, hotels, offices and other facilities were traditionally cleaned by low-cost laborers, now at risk of Covid. Today, institutions are deploying autonomous robots that clean deeper, cheaper.”

— Brian Hart, CEO

TYNGSBORO, MASSACHUSETTS, USA, February 25, 2021 /EINPresswire.com/ — Two leading healthcare providers in New York state recently began sanitizing their facilities in Rochester, New York, and outlying clinics with a new breed of leading edge, autonomous robots, according to Brian Hart, CEO of Black-I Environmental. Black-i’s PureTech brand autonomous robots are programmed to safely sanitize space at half the cost and in half the time of most traditional methods, Hart says.

Hospitals need disinfection around the clock. Traditionally, that job was handled by low-paid workers using water, soap, rags and elbow grease. Now, these workers risk catching the Covid virus and bringing it back to family and friends. Given that labor for such jobs are scarce and getting more so, hospitals, professional cleaning companies, hotels, restaurants, schools, real estate managers and others have been looking for alternatives. Increasingly they are looking to technology to help.

“Autonomous robots are available virtually 24×7, making them perfect for cleaning any indoor space that requires deep and constant sanitizing, which today is virtualy all facilities, "Hart says. “Robots never get sick, never get tired and never ask for a raise. They pay for themselves in a matter of months, while cleaning orders of magnitude better than in the past.”

Black-I Environmental is part of the Black-I Robotics family, which has been in the robotics business since 2008. Its compact, powerful robots — equipped with computers, cameras, laser radars and collision sensors — are programmed to move safely on their own through mapped surgical suites, nursing stations, examination rooms and other facilities using ultraviolet light (UV-C) to destroy the DNA of viruses, bacteria, fungi and other pathogens, Hart says. “The robot not only decontaminates surfaces, its HEPA filters purify the air, capturing up to 99.7 percent of all contaminants 0.3 microns or greater.”

Black-I, headquartered in Tyngsboro, MA, has designed and deployed robotic systems for the Department of Defense, the Department of Homeland Security, the Army Corps of Engineers, and a range of well-known universities, including Princeton, and MIT.

Hart, citing studies, says the need for disinfectant robots will continue to grow exponentially because the virus isn’t going away. “Experts agree that the CoV-2 virus will be with us basically forever,” Hart says, quoting Stephane Bancal, the CEO of Moderna, which designed one of the first vaccines. “The virus continues to mutate rapidly, with most variants more deadly and transmissible than the original strain,” Hart explains.

Hart points out that hospitals have had to cut back on many procedures, both “elective” and non-elective due to Covid. “People are afraid to go to the hospital, afraid even when their lives may depend on surgery, chemo or other treatment,” he says, “Besides the devastating effects on the sick, the pandemic has had a profound effect on hospital revenues and healthcare workers’ income."

Black-I worked closely with Rochester-based CleanCraft, the professional cleaning company, to develop and execute a plan that hospital staff embraced. The plan included training by Black-I of CleanCraft staff to program and operate the robot. Training was completed in less than 20 hours.

Want to know more? Deploying autonomous robots in healthcare and other institutions isn’t difficult. Ask for our DISINFECTING YOUR HOSPITAL: A CASE STUDY which details høw the work was done in Rochester, providing a blueprint for bringing the latest technology to bear on the pandemic.

Brian T. Hart
Black-I EnvironmentaI, Inc.
+1 978-703-1236
brian@blackirobotics.com

Black-I Environmental PureTech autonomous ultraviolet (UV-C) robot sterilizing hospitsl nurses’ station, Rochester, NY


Source: EIN Presswire